Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP

Guest: Danielle O’Laughlin, PA-C, MS

In this episode, along with host/guest Danielle O’Laughlin, PA-C, MS, we will discuss benign, inflammatory breast conditions. We will cover how to differentiate between common issues such as mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia. We’ll walk through the key signs and symptoms to watch for and explore how each condition is diagnosed and treated. This episode offers valuable insights into these non-cancerous yet very important conditions.

By the end of this podcasts, listeners will be able to:

1. Differentiate the benign, inflammatory breast conditions including mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia.
2. Recognize the signs and symptoms for benign, inflammatory breast conditions.
3. Summarize the diagnosis and treatment options for benign, inflammatory breast conditions.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development

Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

Host: Darryl S. Chutka, M.D.

Guests: Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D.

Occasional heartburn from gastroesophageal reflux is usually nothing more than an occasional nuisance for most patients. However, when the reflux becomes chronic, it can become more serious. One complication is Barrett’s esophagus. On occasion, Barrett’s can develop into esophageal adenocarcinoma, an aggressive malignancy with a survival rate of only around 20% at 5 years. Although usually seen in those with chronic acid reflux, Barrett’s can occasionally occur in those without any clinical evidence of acid reflux. When should a patient with acid reflux receive an upper endoscopy? What’s the significance of finding Barrett’s esophagus on an endoscopy? How often does Barrett’s develop into esophageal cancer and does treatment prevent this from happening? In this podcast, these are just some of the questions I’ll be asking our guests, Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D., both from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss Barrett’s Esophagus.

Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

Host: Denise M. Dupras, M.D., Ph.D.

Guest: Michael Zimmer, Ph.D., Director of Rare Diseases at Moderna Therapeutics

This episode of Genes & Your Health welcomes Dr. Michael Zimmer from Moderna Therapeutics, who discusses how mRNA technology is being applied to treat rare genetic diseases, especially liver-based metabolic disorders. Dr. Zimmer explains how mRNA can help the body produce missing proteins, the challenges of delivering these therapies, and the promise they hold for previously untreatable conditions.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts